Skip to main content
WCGIC 2023 Main banner
Back

Eileen M. O'Reilly, MD

Memorial Sloan Kettering Cancer Center
New York, United States

Eileen M. O’Reilly holds the Winthrop Rockefeller Endowed Chair in Medical Oncology at Memorial Sloan Kettering (MSK). She serves as the Section Head for Hepatopancreaticobiliary/ Neuroendocrine Cancers, Gastrointestinal Oncology Service, Co-Director for Medical Initiatives at the David M. Rubenstein Center for Pancreatic Cancer and is an Attending Physician and Member at MSK and Professor of Medicine at Weill Cornell Medical College.

Dr. O’Reilly received her medical degree at Trinity College in Ireland. She completed her postgraduate training in Ireland and subsequent Hematology/Oncology Fellowship training at MSK. Dr. O’Reilly is a clinical scientist whose research focus involves integration of molecular and genetic-based therapies for pancreas cancer along with development of adjuvant and neoadjuvant treatments and identification of biomarkers for therapy selection. Dr. O’Reilly has numerous teaching and awards. Dr. O’Reilly is the Principal Investigator of several trials in pancreas cancer. She serves as an Associate Editor for the Journal of Clinical Oncology and Senior Editor for several other journals and has served on multiple grant review panels including, for ASCO, AACR, NIH, and DOD. She is the PI of the NCI funded MSK Pancreas SPORE. Dr. O’Reilly is the recipient of numerous awards including the Burkitt Medal (TCD) in 2022.

Dr. O’Reilly is the Chair of the MSK IRB. Nationally, Dr. O’Reilly is Co-Chair of the NCI Alliance Co-Operative Group Gastrointestinal Cancers Committee and serves on the NCI Gastrointestinal Cancers Steering Committee (GISC), Medical and Scientific Advisory Board of Pancreatic Cancer Action Network, and the Board of the National Pancreas Foundation.

Presentation(s):